Cigna Corporation Financial Statements (CI)
|
|
|
|
Report date
|
|
|
02.05.2025 |
31.07.2025 |
30.10.2025 |
26.02.2026 |
30.04.2026 |
|
30.04.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
65 502 |
67 230 |
69 748 |
72 472 |
68 494 |
|
277 944 |
|
Operating Income, bln rub |
|
|
1 971 |
2 432 |
2 578 |
2 148 |
2 358 |
|
9 516 |
|
EBITDA, bln rub |
? |
|
3 059 |
3 040 |
3 339 |
2 544 |
3 008 |
|
11 931 |
|
Net profit, bln rub |
? |
|
1 323 |
1 532 |
1 868 |
1 234 |
1 654 |
|
6 288 |
|
|
OCF, bln rub |
? |
|
1 920 |
-1 886 |
3 418 |
6 149 |
1 131 |
|
8 812 |
|
CAPEX, bln rub |
? |
|
327.0 |
285.0 |
278.0 |
322.0 |
267.0 |
|
1 152 |
|
FCF, bln rub |
? |
|
1 593 |
-2 171 |
3 140 |
5 827 |
864.0 |
|
7 660 |
|
Dividend payout, bln rub
|
|
|
412.0 |
401.0 |
402.0 |
396.0 |
417.0 |
|
1 616 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
31.1% |
26.2% |
21.5% |
32.1% |
25.2% |
|
25.7% |
|
|
OPEX, bln rub |
|
|
4 635 |
5 454 |
3 362 |
3 406 |
4 112 |
|
16 334 |
|
Cost of production, bln rub |
|
|
58 896 |
59 344 |
63 808 |
66 918 |
62 024 |
|
252 094 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
362.0 |
337.0 |
347.0 |
335.0 |
357.0 |
|
1 376 |
|
|
Assets, bln rub |
|
|
150 658 |
151 651 |
157 919 |
157 919 |
153 266 |
|
153 266 |
|
Net Assets, bln rub |
? |
|
40 226 |
40 214 |
41 805 |
41 713 |
42 210 |
|
42 210 |
|
Debt, bln rub |
|
|
30 448 |
30 768 |
34 040 |
31 463 |
30 900 |
|
30 900 |
|
Cash, bln rub |
|
|
9 061 |
5 142 |
6 908 |
7 676 |
7 852 |
|
7 852 |
|
Net debt, bln rub |
|
|
21 387 |
25 626 |
27 132 |
23 787 |
23 048 |
|
23 048 |
|
|
Ordinary share price, rub |
|
|
329.0 |
330.6 |
288.3 |
275.2 |
266.8 |
|
284.5 |
|
Number of ordinary shares, mln |
|
|
280.3 |
266.2 |
266.2 |
265.9 |
262.5 |
|
262.5 |
|
|
Market cap, bln rub |
|
|
92 217 |
87 994 |
76 727 |
73 197 |
70 032 |
|
74 682 |
|
EV, bln rub |
? |
|
113 604 |
113 620 |
103 859 |
96 984 |
93 080 |
|
97 730 |
|
Book value, bln rub |
|
|
-33 191 |
-32 832 |
-32 094 |
-31 771 |
-30 642 |
|
-30 642 |
|
|
EPS, rub |
? |
|
4.72 |
5.76 |
7.02 |
4.64 |
6.30 |
|
24.0 |
|
FCF/share, rub |
|
|
5.68 |
-8.16 |
11.8 |
21.9 |
3.29 |
|
29.2 |
|
BV/share, rub |
|
|
-118.4 |
-123.3 |
-120.6 |
-119.5 |
-116.7 |
|
-116.7 |
|
|
EBITDA margin, % |
? |
|
4.67% |
4.52% |
4.79% |
3.51% |
4.39% |
|
4.29% |
|
Net margin, % |
? |
|
2.02% |
2.28% |
2.68% |
1.70% |
2.41% |
|
2.26% |
|
FCF yield, % |
? |
|
6.52% |
4.48% |
9.69% |
11.5% |
10.9% |
|
10.3% |
|
ROE, % |
? |
|
12.5% |
12.5% |
14.7% |
14.3% |
14.9% |
|
14.9% |
|
ROA, % |
? |
|
3.34% |
3.31% |
3.89% |
3.77% |
4.10% |
|
4.10% |
|
|
P/E |
? |
|
18.3 |
17.5 |
12.5 |
12.3 |
11.1 |
|
11.9 |
|
P/FCF |
|
|
15.3 |
22.3 |
10.3 |
8.73 |
9.14 |
|
9.75 |
|
P/S |
? |
|
0.36 |
0.34 |
0.29 |
0.27 |
0.25 |
|
0.27 |
|
P/BV |
? |
|
-2.78 |
-2.68 |
-2.39 |
-2.30 |
-2.29 |
|
-2.44 |
|
EV/EBITDA |
? |
|
9.09 |
9.21 |
8.39 |
8.09 |
7.80 |
|
8.19 |
|
Debt/EBITDA |
|
|
1.71 |
2.08 |
2.19 |
1.99 |
1.93 |
|
1.93 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
0.50% |
0.42% |
0.40% |
0.44% |
0.39% |
|
0.41% |
|
| Cigna Corporation shareholders |
